The Role of Vitamin D and Its Molecular Bases in Insulin Resistance, Diabetes, Metabolic Syndrome, and Cardiovascular Disease: State of the Art
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
In the last decade, an increasing awareness was directed to the role of Vitamin D in non-skeletal and preventive roles for chronic diseases. Vitamin D is an essential hormone in regulating calcium/phosphorous balance and in the pathogenesis of inflammation, insulin resistance, and obesity. The main forms of vitamin D, Cholecalciferol (Vitamin D3) and Ergocalciferol (Vitamin D2) are converted into the active form (1,25-dihydroxyvitamin D) thanks to two hydroxylations in the liver, kidney, pancreas, and immune cells. Some anti-inflammatory cytokines are produced at higher levels by vitamin D, while some pro-inflammatory cytokines are released at lower levels. Toll-Like Receptor (TLR) expression is increased, and a pro-inflammatory state is also linked to low levels of vitamin D. Regardless of how it affects inflammation, various pathways suggest that vitamin D directly improves insulin sensitivity and secretion. The level of vitamin D in the body may change the ratio of pro- to anti-inflammatory cytokines, which would impact insulin action, lipid metabolism, and the development and function of adipose tissue. Many studies have demonstrated an inverse relationship between vitamin D concentrations and pro-inflammatory markers, insulin resistance, glucose intolerance, metabolic syndrome, obesity, and cardiovascular disease. It is interesting to note that several long-term studies also revealed an inverse correlation between vitamin D levels and the occurrence of diabetes mellitus. Vitamin D supplementation in people has controversial effects. While some studies demonstrated improvements in insulin sensitivity, glucose, and lipid metabolism, others revealed no significant effect on glycemic homeostasis and inflammation. This review aims to provide insight into the molecular basis of the relationship between vitamin D, insulin resistance, metabolic syndrome, type 1 and 2 diabetes, gestational diabetes, and cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Holick, M. F. (2007) · New England Journal of Medicine · doi:10.1056/nejmra070553 · Cited by 13,720
Wang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., Coates, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31012-1 · Cited by 6,596
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Zheng, Y., Ley, S. H., & Hu, F. B. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.151 · Cited by 5,697 · cited 1×
“T2DM constitutes an essential risk factor for premature death and adverse complications, micro and macrovascular, such as blindness, stroke, heart attack, amputation, and kidney failure [50], and also determines and impairs quality of life [51].”
Background2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
The Global Epidemic of the Metabolic Syndrome
Saklayen, M. G. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0812-z · Cited by 3,990
Vitamin D metabolism, mechanism of action, and clinical applications
Bikle, D. D. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.12.016 · Cited by 1,933
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
Li, Y. C., Kong, J., Wei, M., Chen, Z.-F., Liu, S. Q., & Cao, L.-P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215219 · Cited by 1,625
2. Classification and Diagnosis of Diabetes
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s005 · Cited by 1,603
Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., & Assi, H. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020786 · Cited by 1,441
Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes
Muoio, D. M., & Newgard, C. B. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2327 · Cited by 1,177 · cited 1×
“Type 2 Diabetes Mellitus is a chronic metabolic disorder characterized by inadequate insulin production and consequentially high blood glucose [49].”
BackgroundNational Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784 · cited 1×
“On the other hand, dyslipidemia is associated with insulin resistance and elevated risk of CVD events [191,192].”
BackgroundPittas, A. G., Harris, S. S., Stark, P. C., & Dawson-Hughes, B. (2007) · Diabetes Care · doi:10.2337/dc06-1994 · Cited by 643
Worldwide childhood type 1 diabetes incidence–what can we learn from epidemiology?
Soltesz, G., Patterson, C., Dahlquist, G., & EURODIAB Study Group (2007) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00280.x · Cited by 371
Total antioxidant capacity: appraisal of a concept
Sies, H. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.6.1493 · Cited by 308
Li, X., Liu, Y., Zheng, Y., Wang, P., & Zhang, Y. (2018) · Nutrients · doi:10.3390/nu10030375 · Cited by 266 · cited 1×
“In another meta-analysis, vitamin D intake significantly decreased insulin resistance in people with T2DM [216].”
BackgroundIn utero dietary exposures and risk of islet autoimmunity in children
Fronczak, C. M., Barón, A. E., Chase, H. P., Ross, C., Brady, H. L., Hoffman, M., Eisenbarth, G. S., Rewers, M., & Norris, J. M. (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3237 · Cited by 223
Karkeni, E., Bonnet, L., Marcotorchino, J., Tourniaire, F., Astier, J., Ye, J., & Landrier, J.-F. (2018) · Epigenetics · doi:10.1080/15592294.2016.1276681 · Cited by 142
Slominski, A. T., Kim, T.-K., Hobrath, J. V., Janjetovic, Z., Oak, A. S. W., Postlethwaite, A., Lin, Z., Li, W., Takeda, Y., Jetten, A. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10202-7 · Cited by 82 · cited 1×
“Furthermore, different nutrients such as vitamins and minerals can also affect the antioxidant balance [202–204].”
BackgroundMilajerdi, A., Abbasi, F., Mousavi, S. M., & Esmaillzadeh, A. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.03.037 · Cited by 64 · cited 1×
“Several longitudinal prospective cohort studies have reported the risk of GDM with serum vitamin D concentrations in early pregnancy [165].”
BackgroundWang, M., Chen, Z., Hu, Y., Wang, Y., Wu, Y., Lian, F., Li, H., Yang, J., & Xu, X. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2020.12.016 · Cited by 63
Nutrition Therapy in Gestational Diabetes Mellitus: Time to Move Forward
Hernandez, T. L., & Brand-Miller, J. C. (2018) · Diabetes Care · doi:10.2337/dci18-0014 · Cited by 52
Metadata
- Authors
- Argano, C., Mirarchi, L., Amodeo, S., Orlando, V., Torres, A., & Corrao, S.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-10-23
- Volume
- 24
- Issue
- 20
- Pages
- 15485
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W4387880327
- Cited by
- 204
- References
- 22
- FWCI
- 33.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.